Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antiviral Therapy
Findings advance knowledge in antiviral therapy research
June 17th, 2005
Reports from the United States, United Kingdom and Germany highlight recent research on antiviral therapy. Study 1: Chronic hepatitis C responds well to interferon alfacon-1 combination therapy. "Despite advances in the therapy of chronic hepatitis C, a large number of patients do not respond to current therapies. The study objective was to assess whether a combination of interferon (IFN) alfacon-1 and ribavirin improves the response rate compared with a combination of INF alpha-2b and ribavirin in chronic hepatitis C subjects," scientists writing in the journal Digestive Diseases and Sciences report. "The study was...
Source: Drug Week (2005-06-17)
|
